Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
2
home,wp-singular,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,wp-theme-bridge,bridge-core-3.0.5,qi-blocks-1.0.6,qodef-gutenberg--no-touch,qodef-qi--no-touch,qi-addons-for-elementor-1.5.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-29.1,qode-theme-bridge,disabled_footer_bottom,wpb-js-composer js-comp-ver-6.9.0,vc_responsive,elementor-default,elementor-kit-3247,x-shortcodes-v3_0_5
Johns Hopkins University Drug Discovery

Transforming academic
translational research

Expertise in drug
discovery research

Developing for the future

What’s New?

JHDD Director Barbara Slusher interviewed for Medical Breakthrough TV series – “The Accidental Discovery to Treat IBD”
Watch the video

JHDD Director Barbara Slusher featured in JH Technology Ventures Innovator Spotlight interview
Watch the video

Sun Pharma Advanced Research Company (SPARC) in-licenses a novel prodrug to treat autoimmune-related hair loss

JHDD and Bloomberg-Kimmel Institute for Cancer Immunotherapy researchers partner on drug that helps suppress prostate and bladder tumor growth.

Blackbird Laboratories, funded by the Bisciotti Foundation, partners with JHDD to develop IBD treatment

Read the article from the Baltimore Banner

JHDD researchers develop gut-restricted drug to treat IBD

Interested in Working With Us?

We welcome opportunities to discuss how we can work together in a drug discovery collaboration.